Approval · Notice of Compliance 2089 · 1999
ZANAFLEX: Notice of Compliance 2089
Issued January 25, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2089
- Date
- January 25, 1999
- Company
- Athena Neurosciences Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antispastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANAFLEX | 02239170 | Cancelled Post Market |
Medicinal ingredients
- TIZANIDINE HCL 4 MG per TAB